This study provides Class II evidence that CSF levels of β-synuclein, α-synuclein, SNAP-25, neurogranin, and NfL are higher in patients with Alzheimer disease than in patients with Lewy body disease. Read the article: bit.ly/3pANlt9
Teacher, Clinical Supervisor, [AIdvisor]
Retired Clinical Associate Professor, Psychiatry, University of Florida
Affiliation is for identification only. All content and opinions are my own.
View more posts
Gator Psychiatry 